Why is Sun Pharmaceutical Industries Ltd ?
1
Flat results in Sep 26
- PAT(Q) At Rs 2,792.38 cr has Fallen at -11.6% (vs previous 4Q average)
- DEBTORS TURNOVER RATIO(HY) Lowest at 3.44 times
- EPS(Q) Lowest at Rs 8.29
2
Stock is technically in a Mildly Bearish range
- The technical trend has deteriorated from Sideways on 20-Nov-26
- A key technical factor - KST has been Bearish since 20 Nov 2026
3
With ROE of 13.8, it has a Expensive valuation with a 5.1 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 6.03%, its profits have risen by 6.6% ; the PEG ratio of the company is 5.6
4
Reducing Promoter Confidence
- Promoters have decreased their stake in the company by -1.8% over the previous quarter and currently hold 52.68% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Sun Pharma.Inds. for you?
Low Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Sun Pharma.Inds.
6.03%
0.31
19.77%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
10.92%
EBIT Growth (5y)
14.10%
EBIT to Interest (avg)
54.75
Debt to EBITDA (avg)
0.26
Net Debt to Equity (avg)
-0.34
Sales to Capital Employed (avg)
0.71
Tax Ratio
26.60%
Dividend Payout Ratio
35.13%
Pledged Shares
0.01%
Institutional Holding
36.62%
ROCE (avg)
22.87%
ROE (avg)
14.99%
Valuation Key Factors 
Factor
Value
P/E Ratio
37
Industry P/E
40
Price to Book Value
5.07
EV to EBIT
28.02
EV to EBITDA
23.36
EV to Capital Employed
7.16
EV to Sales
6.85
PEG Ratio
5.59
Dividend Yield
0.85%
ROCE (Latest)
25.55%
ROE (Latest)
13.79%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Movement
3What is working for the Company
CASH AND CASH EQUIVALENTS(HY)
Highest at Rs 20,368.37 cr
NET SALES(Q)
Highest at Rs 16,198.71 cr
-6What is not working for the Company
PAT(Q)
At Rs 2,792.38 cr has Fallen at -11.6% (vs previous 4Q average
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.44 times
EPS(Q)
Lowest at Rs 8.29
Loading Valuation Snapshot...
Here's what is working for Sun Pharma.Inds.
Net Sales - Quarterly
Highest at Rs 16,198.71 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Cash and Cash Equivalents - Half Yearly
Highest at Rs 20,368.37 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Here's what is not working for Sun Pharma.Inds.
Profit After Tax (PAT) - Quarterly
At Rs 2,792.38 cr has Fallen at -11.6% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 3,158.59 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Lowest at Rs 8.29
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)
Debtors Turnover Ratio- Half Yearly
Lowest at 3.44 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio